GynecologyGynecology2079-56962079-5831Consilium Medicum27293Research ArticleOsobennosti epidemiologii i sovremennye metody diagnostiki zlokachestvennykh opukholey yaichnikovNovikovaE R-RoninaE A-1504199912424509042020Copyright © 1999, Consilium Medicum1999[Ганиева Г.Ю. Алгоритмы дифференциальной диагностики тубоовариальных образований. Дис. .канд. мед. наук., Уфа, 1996.][Жордания К.И. Оптимизация диагностики и лечения рака яичников. Дис. ... д - ра мед. наук. М., 1993.][Averette H.E., Donato D.M. Ovarian carcinoma. Advanced in diagnosis, staging and treatment. // Cancer 1990; 65(3): 703-8.][Bourne T.H., Reynolds K., Campbell S. Ovarian cancer screening. // Curr-Opin-Radiol, 1991; 3 (2): 216-24.][Manys G. Epidemiological factors in ovarian cancer. // 9th international meeting of gynaecological oncology. Abstract book. - Knokke, 1995; 20.][Amos C., Struewing J. Genetic epidemiology of epithelial cancer. 1993; 71: 566-70.][King M.C., Go R.C.P., Lynch H.T., Elston R.C. Genetic epidemiology of breast cancer and associated cancer in high - risk, families. II Linkage analysis. J. Nat. Cancer Inst. 1983; 71 (3): 463-7.][Lynch H.T., Albano W.A., Neieck J.J., Mulcahy G.M., Lynch J.F. Genetics biomarkers and control of breast cancer: a rewiew. Cancer Genet Cytogenet 1984; 13 (1): 43-92.][Сидоренко Ю.С., Неродо Г.А. Зависимость постановки диагноза от степени клинического проявления злокачественной опухоли гениталий. // Актуальные вопросы онкологии. - Барнаул, 1992; 173-5.][Farghaly S.A. et al. Screening for ovarian cancer 1995. Were do we stand? // 9th international meeting of gynaeco - logical oncology. Abstract book. - Knokke, 1995; 155.][Gallion H.H., Park R. Developing Intervention/ prevention strategies for individuals at high risk of developing hereditary ovarian cancer. // Journal of the National Cancer Institute Monographs, 1995; 17: 103-6.][Винокуров В.Л., Дударев А.Д., Юркова Л.Е., Лапченков В.И. Са-125 in the diagnosis, monitoring managment and follow - up of patients with ovarian tumors. //Eur. J. Gynecol. Oncol. 1991; XII (Suppl): 142.][Леонова Н.В. Ультразвуковая диагностика рецидивов злокачественных опухолей яичников. Дис. .канд. мед. наук. М., 1993.][Sawicki W., Spiewankiewicz B., Cendrowski K. Transvaginal colour flow imaging in assessment of ovarian tumors neovascularization. // 9th international meeting of gynaecological oncology. Abstract book. - Knokke, 1995; 20.][Wu C-C., Lee C-N., Chen T-M., Lai J-I. et al. Factors contributing to the accuracy in diagnosing ovarian malignancy by color doppler ultrasound. // Obstetrics & gynecology. 1994; 84 (4): 605-9.][Inoue M., Fujita M., Nakazawa A., Ogawa H., Tanizawa O. Sialyl-Tn, sialyl-Lewis Xi, CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors. // Obstet-Gynecol. 1992; 79(3): 434-40.][Rastin G.J. Tumor marcers of ovarian cancer. // Eur. J. Cancer. 1992; 28 (1): 2-3.]